- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x SFG: SINEFUNGIN(Non-covalent)
- 4 x 01: 2-(cyclobutylamino)-N-{(2R)-2-hydroxy-2-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]ethyl}pyridine-4-carboxamide
01.2: 23 residues within 4Å:- Chain A: F.308, A.309, Y.312, Q.317, L.320, L.327, T.331, Y.332, V.334, F.335, K.341, E.443, L.445, G.446, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Ligands: SFG.1, SO4.25
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:F.308, A:Y.312, A:L.327, A:F.335, A:V.511, A:F.585, A:F.588, A:F.588
- Hydrogen bonds: A:F.585, A:W.587, A:F.588
- pi-Stacking: A:F.335, A:F.335
01.34: 23 residues within 4Å:- Chain C: F.308, A.309, Y.312, Q.317, L.320, L.327, T.331, Y.332, V.334, F.335, K.341, E.443, L.445, G.446, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Ligands: SFG.33, SO4.57
13 PLIP interactions:13 interactions with chain C- Hydrophobic interactions: C:F.308, C:Y.312, C:L.327, C:F.335, C:V.511, C:F.585, C:F.588, C:F.588
- Hydrogen bonds: C:F.585, C:W.587, C:F.588
- pi-Stacking: C:F.335, C:F.335
01.66: 23 residues within 4Å:- Chain E: F.308, A.309, Y.312, Q.317, L.320, L.327, T.331, Y.332, V.334, F.335, K.341, E.443, L.445, G.446, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Ligands: SFG.65, SO4.89
13 PLIP interactions:13 interactions with chain E- Hydrophobic interactions: E:F.308, E:Y.312, E:L.327, E:F.335, E:V.511, E:F.585, E:F.588, E:F.588
- Hydrogen bonds: E:F.585, E:W.587, E:F.588
- pi-Stacking: E:F.335, E:F.335
01.98: 23 residues within 4Å:- Chain G: F.308, A.309, Y.312, Q.317, L.320, L.327, T.331, Y.332, V.334, F.335, K.341, E.443, L.445, G.446, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Ligands: SFG.97, SO4.121
13 PLIP interactions:13 interactions with chain G- Hydrophobic interactions: G:F.308, G:Y.312, G:L.327, G:F.335, G:V.511, G:F.585, G:F.588, G:F.588
- Hydrogen bonds: G:F.585, G:W.587, G:F.588
- pi-Stacking: G:F.335, G:F.335
- 76 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 7 residues within 4Å:- Chain A: P.403, V.406, V.407, E.410, S.425
- Chain G: Q.74
- Ligands: PEG.125
Ligand excluded by PLIPEDO.4: 10 residues within 4Å:- Chain A: P.164, L.165, V.166, L.171, E.215, I.216, G.217, D.219, L.220, P.221
Ligand excluded by PLIPEDO.5: 10 residues within 4Å:- Chain A: W.194, M.195, H.198, R.228, N.553, T.554, V.555, T.599, V.600
- Ligands: EDO.51
Ligand excluded by PLIPEDO.6: 10 residues within 4Å:- Chain A: E.328, S.329, Q.330
- Chain G: G.83, W.86, N.87, Y.124, L.125, G.126
- Ligands: EDO.18
Ligand excluded by PLIPEDO.7: 5 residues within 4Å:- Chain A: I.150, Y.206, S.207, K.208, R.493
Ligand excluded by PLIPEDO.8: 11 residues within 4Å:- Chain A: W.194, R.201, L.230, G.231, E.232, S.484, S.485, S.486, V.555, H.557
- Ligands: EDO.11
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain A: S.95, P.96, R.99, P.133, N.135
- Chain B: Q.177
- Ligands: PEG.28
Ligand excluded by PLIPEDO.10: 8 residues within 4Å:- Chain A: W.197, R.201, C.204, D.205, Y.206, S.207, I.210, N.490
Ligand excluded by PLIPEDO.11: 12 residues within 4Å:- Chain A: W.194, D.227, R.228, L.230, E.232, S.484, H.518, L.520, N.553, T.554, V.555
- Ligands: EDO.8
Ligand excluded by PLIPEDO.12: 7 residues within 4Å:- Chain A: L.116, Q.117, N.120, F.121
- Chain G: P.403, N.404
- Ligands: PEG.29
Ligand excluded by PLIPEDO.13: 7 residues within 4Å:- Chain A: K.93, L.94, L.131, L.132, P.133, R.162
- Ligands: PEG.28
Ligand excluded by PLIPEDO.14: 9 residues within 4Å:- Chain A: I.226, D.227, W.229, L.230, I.234, L.261, R.264, L.265, L.268
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain A: N.533, D.535, M.537, I.538, D.539, R.542
Ligand excluded by PLIPEDO.16: 5 residues within 4Å:- Chain A: I.538, D.539, N.540, N.541, S.614
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain A: G.83, R.84, N.87
- Chain G: Q.330
Ligand excluded by PLIPEDO.18: 11 residues within 4Å:- Chain A: S.329, Q.330, E.333, R.376
- Chain G: D.78, L.79, L.81, S.82, G.83, W.86
- Ligands: EDO.6
Ligand excluded by PLIPEDO.19: 8 residues within 4Å:- Chain A: T.626, P.628, V.629, C.630
- Chain C: M.195, H.198, N.199
- Ligands: EDO.37
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain B: A.182, A.183, A.227, W.228, F.271
Ligand excluded by PLIPEDO.31: 9 residues within 4Å:- Chain A: V.104, K.106, I.107
- Chain B: E.241, N.242, G.243, S.263, Q.264, C.265
Ligand excluded by PLIPEDO.35: 7 residues within 4Å:- Chain C: P.403, V.406, V.407, E.410, S.425
- Chain E: Q.74
- Ligands: PEG.93
Ligand excluded by PLIPEDO.36: 10 residues within 4Å:- Chain C: P.164, L.165, V.166, L.171, E.215, I.216, G.217, D.219, L.220, P.221
Ligand excluded by PLIPEDO.37: 10 residues within 4Å:- Chain C: W.194, M.195, H.198, R.228, N.553, T.554, V.555, T.599, V.600
- Ligands: EDO.19
Ligand excluded by PLIPEDO.38: 10 residues within 4Å:- Chain C: E.328, S.329, Q.330
- Chain E: G.83, W.86, N.87, Y.124, L.125, G.126
- Ligands: EDO.50
Ligand excluded by PLIPEDO.39: 5 residues within 4Å:- Chain C: I.150, Y.206, S.207, K.208, R.493
Ligand excluded by PLIPEDO.40: 11 residues within 4Å:- Chain C: W.194, R.201, L.230, G.231, E.232, S.484, S.485, S.486, V.555, H.557
- Ligands: EDO.43
Ligand excluded by PLIPEDO.41: 7 residues within 4Å:- Chain C: S.95, P.96, R.99, P.133, N.135
- Chain D: Q.177
- Ligands: PEG.60
Ligand excluded by PLIPEDO.42: 8 residues within 4Å:- Chain C: W.197, R.201, C.204, D.205, Y.206, S.207, I.210, N.490
Ligand excluded by PLIPEDO.43: 12 residues within 4Å:- Chain C: W.194, D.227, R.228, L.230, E.232, S.484, H.518, L.520, N.553, T.554, V.555
- Ligands: EDO.40
Ligand excluded by PLIPEDO.44: 7 residues within 4Å:- Chain C: L.116, Q.117, N.120, F.121
- Chain E: P.403, N.404
- Ligands: PEG.61
Ligand excluded by PLIPEDO.45: 7 residues within 4Å:- Chain C: K.93, L.94, L.131, L.132, P.133, R.162
- Ligands: PEG.60
Ligand excluded by PLIPEDO.46: 9 residues within 4Å:- Chain C: I.226, D.227, W.229, L.230, I.234, L.261, R.264, L.265, L.268
Ligand excluded by PLIPEDO.47: 6 residues within 4Å:- Chain C: N.533, D.535, M.537, I.538, D.539, R.542
Ligand excluded by PLIPEDO.48: 5 residues within 4Å:- Chain C: I.538, D.539, N.540, N.541, S.614
Ligand excluded by PLIPEDO.49: 4 residues within 4Å:- Chain C: G.83, R.84, N.87
- Chain E: Q.330
Ligand excluded by PLIPEDO.50: 11 residues within 4Å:- Chain C: S.329, Q.330, E.333, R.376
- Chain E: D.78, L.79, L.81, S.82, G.83, W.86
- Ligands: EDO.38
Ligand excluded by PLIPEDO.51: 8 residues within 4Å:- Chain A: M.195, H.198, N.199
- Chain C: T.626, P.628, V.629, C.630
- Ligands: EDO.5
Ligand excluded by PLIPEDO.62: 5 residues within 4Å:- Chain D: A.182, A.183, A.227, W.228, F.271
Ligand excluded by PLIPEDO.63: 9 residues within 4Å:- Chain C: V.104, K.106, I.107
- Chain D: E.241, N.242, G.243, S.263, Q.264, C.265
Ligand excluded by PLIPEDO.67: 7 residues within 4Å:- Chain C: Q.74
- Chain E: P.403, V.406, V.407, E.410, S.425
- Ligands: PEG.61
Ligand excluded by PLIPEDO.68: 10 residues within 4Å:- Chain E: P.164, L.165, V.166, L.171, E.215, I.216, G.217, D.219, L.220, P.221
Ligand excluded by PLIPEDO.69: 10 residues within 4Å:- Chain E: W.194, M.195, H.198, R.228, N.553, T.554, V.555, T.599, V.600
- Ligands: EDO.115
Ligand excluded by PLIPEDO.70: 10 residues within 4Å:- Chain C: G.83, W.86, N.87, Y.124, L.125, G.126
- Chain E: E.328, S.329, Q.330
- Ligands: EDO.82
Ligand excluded by PLIPEDO.71: 5 residues within 4Å:- Chain E: I.150, Y.206, S.207, K.208, R.493
Ligand excluded by PLIPEDO.72: 11 residues within 4Å:- Chain E: W.194, R.201, L.230, G.231, E.232, S.484, S.485, S.486, V.555, H.557
- Ligands: EDO.75
Ligand excluded by PLIPEDO.73: 7 residues within 4Å:- Chain E: S.95, P.96, R.99, P.133, N.135
- Chain F: Q.177
- Ligands: PEG.92
Ligand excluded by PLIPEDO.74: 8 residues within 4Å:- Chain E: W.197, R.201, C.204, D.205, Y.206, S.207, I.210, N.490
Ligand excluded by PLIPEDO.75: 12 residues within 4Å:- Chain E: W.194, D.227, R.228, L.230, E.232, S.484, H.518, L.520, N.553, T.554, V.555
- Ligands: EDO.72
Ligand excluded by PLIPEDO.76: 7 residues within 4Å:- Chain C: P.403, N.404
- Chain E: L.116, Q.117, N.120, F.121
- Ligands: PEG.93
Ligand excluded by PLIPEDO.77: 7 residues within 4Å:- Chain E: K.93, L.94, L.131, L.132, P.133, R.162
- Ligands: PEG.92
Ligand excluded by PLIPEDO.78: 9 residues within 4Å:- Chain E: I.226, D.227, W.229, L.230, I.234, L.261, R.264, L.265, L.268
Ligand excluded by PLIPEDO.79: 6 residues within 4Å:- Chain E: N.533, D.535, M.537, I.538, D.539, R.542
Ligand excluded by PLIPEDO.80: 5 residues within 4Å:- Chain E: I.538, D.539, N.540, N.541, S.614
Ligand excluded by PLIPEDO.81: 4 residues within 4Å:- Chain C: Q.330
- Chain E: G.83, R.84, N.87
Ligand excluded by PLIPEDO.82: 11 residues within 4Å:- Chain C: D.78, L.79, L.81, S.82, G.83, W.86
- Chain E: S.329, Q.330, E.333, R.376
- Ligands: EDO.70
Ligand excluded by PLIPEDO.83: 8 residues within 4Å:- Chain E: T.626, P.628, V.629, C.630
- Chain G: M.195, H.198, N.199
- Ligands: EDO.101
Ligand excluded by PLIPEDO.94: 5 residues within 4Å:- Chain F: A.182, A.183, A.227, W.228, F.271
Ligand excluded by PLIPEDO.95: 9 residues within 4Å:- Chain E: V.104, K.106, I.107
- Chain F: E.241, N.242, G.243, S.263, Q.264, C.265
Ligand excluded by PLIPEDO.99: 7 residues within 4Å:- Chain A: Q.74
- Chain G: P.403, V.406, V.407, E.410, S.425
- Ligands: PEG.29
Ligand excluded by PLIPEDO.100: 10 residues within 4Å:- Chain G: P.164, L.165, V.166, L.171, E.215, I.216, G.217, D.219, L.220, P.221
Ligand excluded by PLIPEDO.101: 10 residues within 4Å:- Chain G: W.194, M.195, H.198, R.228, N.553, T.554, V.555, T.599, V.600
- Ligands: EDO.83
Ligand excluded by PLIPEDO.102: 10 residues within 4Å:- Chain A: G.83, W.86, N.87, Y.124, L.125, G.126
- Chain G: E.328, S.329, Q.330
- Ligands: EDO.114
Ligand excluded by PLIPEDO.103: 5 residues within 4Å:- Chain G: I.150, Y.206, S.207, K.208, R.493
Ligand excluded by PLIPEDO.104: 11 residues within 4Å:- Chain G: W.194, R.201, L.230, G.231, E.232, S.484, S.485, S.486, V.555, H.557
- Ligands: EDO.107
Ligand excluded by PLIPEDO.105: 7 residues within 4Å:- Chain G: S.95, P.96, R.99, P.133, N.135
- Chain H: Q.177
- Ligands: PEG.124
Ligand excluded by PLIPEDO.106: 8 residues within 4Å:- Chain G: W.197, R.201, C.204, D.205, Y.206, S.207, I.210, N.490
Ligand excluded by PLIPEDO.107: 12 residues within 4Å:- Chain G: W.194, D.227, R.228, L.230, E.232, S.484, H.518, L.520, N.553, T.554, V.555
- Ligands: EDO.104
Ligand excluded by PLIPEDO.108: 7 residues within 4Å:- Chain A: P.403, N.404
- Chain G: L.116, Q.117, N.120, F.121
- Ligands: PEG.125
Ligand excluded by PLIPEDO.109: 7 residues within 4Å:- Chain G: K.93, L.94, L.131, L.132, P.133, R.162
- Ligands: PEG.124
Ligand excluded by PLIPEDO.110: 9 residues within 4Å:- Chain G: I.226, D.227, W.229, L.230, I.234, L.261, R.264, L.265, L.268
Ligand excluded by PLIPEDO.111: 6 residues within 4Å:- Chain G: N.533, D.535, M.537, I.538, D.539, R.542
Ligand excluded by PLIPEDO.112: 5 residues within 4Å:- Chain G: I.538, D.539, N.540, N.541, S.614
Ligand excluded by PLIPEDO.113: 4 residues within 4Å:- Chain A: Q.330
- Chain G: G.83, R.84, N.87
Ligand excluded by PLIPEDO.114: 11 residues within 4Å:- Chain A: D.78, L.79, L.81, S.82, G.83, W.86
- Chain G: S.329, Q.330, E.333, R.376
- Ligands: EDO.102
Ligand excluded by PLIPEDO.115: 8 residues within 4Å:- Chain E: M.195, H.198, N.199
- Chain G: T.626, P.628, V.629, C.630
- Ligands: EDO.69
Ligand excluded by PLIPEDO.126: 5 residues within 4Å:- Chain H: A.182, A.183, A.227, W.228, F.271
Ligand excluded by PLIPEDO.127: 9 residues within 4Å:- Chain G: V.104, K.106, I.107
- Chain H: E.241, N.242, G.243, S.263, Q.264, C.265
Ligand excluded by PLIP- 32 x SO4: SULFATE ION(Non-functional Binders)
SO4.20: 6 residues within 4Å:- Chain A: E.336, R.376, G.377, P.378, N.381, W.412
Ligand excluded by PLIPSO4.21: 6 residues within 4Å:- Chain A: F.48, T.88, V.91, P.128, W.160, Q.271
Ligand excluded by PLIPSO4.22: 4 residues within 4Å:- Chain A: L.316, Q.317, S.318, Y.510
Ligand excluded by PLIPSO4.23: 3 residues within 4Å:- Chain A: F.517, H.518, Q.519
Ligand excluded by PLIPSO4.24: 5 residues within 4Å:- Chain A: G.638, R.639, S.640, Y.641, T.642
Ligand excluded by PLIPSO4.25: 5 residues within 4Å:- Chain A: Y.312, T.331, V.334, F.335
- Ligands: 01.2
Ligand excluded by PLIPSO4.26: 4 residues within 4Å:- Chain A: S.426, E.430, W.431, V.432
Ligand excluded by PLIPSO4.32: 3 residues within 4Å:- Chain B: H.274, S.275, H.318
Ligand excluded by PLIPSO4.52: 6 residues within 4Å:- Chain C: E.336, R.376, G.377, P.378, N.381, W.412
Ligand excluded by PLIPSO4.53: 6 residues within 4Å:- Chain C: F.48, T.88, V.91, P.128, W.160, Q.271
Ligand excluded by PLIPSO4.54: 4 residues within 4Å:- Chain C: L.316, Q.317, S.318, Y.510
Ligand excluded by PLIPSO4.55: 3 residues within 4Å:- Chain C: F.517, H.518, Q.519
Ligand excluded by PLIPSO4.56: 5 residues within 4Å:- Chain C: G.638, R.639, S.640, Y.641, T.642
Ligand excluded by PLIPSO4.57: 5 residues within 4Å:- Chain C: Y.312, T.331, V.334, F.335
- Ligands: 01.34
Ligand excluded by PLIPSO4.58: 4 residues within 4Å:- Chain C: S.426, E.430, W.431, V.432
Ligand excluded by PLIPSO4.64: 3 residues within 4Å:- Chain D: H.274, S.275, H.318
Ligand excluded by PLIPSO4.84: 6 residues within 4Å:- Chain E: E.336, R.376, G.377, P.378, N.381, W.412
Ligand excluded by PLIPSO4.85: 6 residues within 4Å:- Chain E: F.48, T.88, V.91, P.128, W.160, Q.271
Ligand excluded by PLIPSO4.86: 4 residues within 4Å:- Chain E: L.316, Q.317, S.318, Y.510
Ligand excluded by PLIPSO4.87: 3 residues within 4Å:- Chain E: F.517, H.518, Q.519
Ligand excluded by PLIPSO4.88: 5 residues within 4Å:- Chain E: G.638, R.639, S.640, Y.641, T.642
Ligand excluded by PLIPSO4.89: 5 residues within 4Å:- Chain E: Y.312, T.331, V.334, F.335
- Ligands: 01.66
Ligand excluded by PLIPSO4.90: 4 residues within 4Å:- Chain E: S.426, E.430, W.431, V.432
Ligand excluded by PLIPSO4.96: 3 residues within 4Å:- Chain F: H.274, S.275, H.318
Ligand excluded by PLIPSO4.116: 6 residues within 4Å:- Chain G: E.336, R.376, G.377, P.378, N.381, W.412
Ligand excluded by PLIPSO4.117: 6 residues within 4Å:- Chain G: F.48, T.88, V.91, P.128, W.160, Q.271
Ligand excluded by PLIPSO4.118: 4 residues within 4Å:- Chain G: L.316, Q.317, S.318, Y.510
Ligand excluded by PLIPSO4.119: 3 residues within 4Å:- Chain G: F.517, H.518, Q.519
Ligand excluded by PLIPSO4.120: 5 residues within 4Å:- Chain G: G.638, R.639, S.640, Y.641, T.642
Ligand excluded by PLIPSO4.121: 5 residues within 4Å:- Chain G: Y.312, T.331, V.334, F.335
- Ligands: 01.98
Ligand excluded by PLIPSO4.122: 4 residues within 4Å:- Chain G: S.426, E.430, W.431, V.432
Ligand excluded by PLIPSO4.128: 3 residues within 4Å:- Chain H: H.274, S.275, H.318
Ligand excluded by PLIP- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.27: 11 residues within 4Å:- Chain A: E.137, D.138, N.139, T.140, W.196, N.199, F.200, L.203
- Chain C: R.609, T.626, C.630
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:D.138, A:N.139, A:W.196, A:N.199, A:F.200
PEG.28: 10 residues within 4Å:- Chain A: D.27, N.29, K.93, L.94, P.96, R.162, T.275
- Chain B: D.134
- Ligands: EDO.9, EDO.13
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:K.93, A:T.275, A:T.275
- Water bridges: A:N.29, A:G.276
PEG.29: 8 residues within 4Å:- Chain A: F.54, Q.74, Q.117
- Chain G: P.403, N.404, V.407
- Ligands: EDO.12, EDO.99
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.117
PEG.59: 11 residues within 4Å:- Chain A: R.609, T.626, C.630
- Chain C: E.137, D.138, N.139, T.140, W.196, N.199, F.200, L.203
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:D.138, C:N.139, C:W.196, C:N.199, C:F.200
PEG.60: 10 residues within 4Å:- Chain C: D.27, N.29, K.93, L.94, P.96, R.162, T.275
- Chain D: D.134
- Ligands: EDO.41, EDO.45
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:K.93, C:T.275, C:T.275
- Water bridges: C:N.29, C:G.276
PEG.61: 8 residues within 4Å:- Chain C: F.54, Q.74, Q.117
- Chain E: P.403, N.404, V.407
- Ligands: EDO.44, EDO.67
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Q.117
PEG.91: 11 residues within 4Å:- Chain E: E.137, D.138, N.139, T.140, W.196, N.199, F.200, L.203
- Chain G: R.609, T.626, C.630
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:N.139, E:W.196, E:N.199, E:F.200
PEG.92: 10 residues within 4Å:- Chain E: D.27, N.29, K.93, L.94, P.96, R.162, T.275
- Chain F: D.134
- Ligands: EDO.73, EDO.77
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:K.93, E:T.275
- Water bridges: E:N.29, E:T.275
PEG.93: 8 residues within 4Å:- Chain C: P.403, N.404, V.407
- Chain E: F.54, Q.74, Q.117
- Ligands: EDO.35, EDO.76
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:Q.117
PEG.123: 11 residues within 4Å:- Chain E: R.609, T.626, C.630
- Chain G: E.137, D.138, N.139, T.140, W.196, N.199, F.200, L.203
4 PLIP interactions:4 interactions with chain G- Hydrogen bonds: G:N.139, G:W.196, G:N.199, G:F.200
PEG.124: 10 residues within 4Å:- Chain G: D.27, N.29, K.93, L.94, P.96, R.162, T.275
- Chain H: D.134
- Ligands: EDO.105, EDO.109
4 PLIP interactions:4 interactions with chain G- Hydrogen bonds: G:K.93, G:T.275
- Water bridges: G:N.29, G:T.275
PEG.125: 8 residues within 4Å:- Chain A: P.403, N.404, V.407
- Chain G: F.54, Q.74, Q.117
- Ligands: EDO.3, EDO.108
1 PLIP interactions:1 interactions with chain G- Hydrogen bonds: G:Q.117
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, K.M. et al., MTA-Cooperative PRMT5 Inhibitors: Mechanism Switching Through Structure-Based Design. J.Med.Chem. (2025)
- Release Date
- 2025-03-05
- Peptides
- Protein arginine N-methyltransferase 5: ACEG
Methylosome protein 50: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AB
BD
BF
BH
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x SFG: SINEFUNGIN(Non-covalent)
- 4 x 01: 2-(cyclobutylamino)-N-{(2R)-2-hydroxy-2-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]ethyl}pyridine-4-carboxamide
- 76 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 32 x SO4: SULFATE ION(Non-functional Binders)
- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, K.M. et al., MTA-Cooperative PRMT5 Inhibitors: Mechanism Switching Through Structure-Based Design. J.Med.Chem. (2025)
- Release Date
- 2025-03-05
- Peptides
- Protein arginine N-methyltransferase 5: ACEG
Methylosome protein 50: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AB
BD
BF
BH
B